Imidazoline binding sites (IBS) profile modulation:: Key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues

被引:31
作者
Gentili, F
Bousquet, P
Brasili, L
Dontenwill, M
Feldman, J
Ghelfi, F
Giannella, M
Piergentili, A
Quaglia, W
Pigini, M
机构
[1] Univ Camerino, Dipartimento Sci Chim, I-62032 Camerino, Italy
[2] Univ Strasbourg 1, Lab Neurobiol & Pharmacol Cardiovasc, F-67000 Strasbourg, France
[3] Univ Modena, Dipartimento Sci Farmaceut, I-41100 Modena, Italy
关键词
D O I
10.1021/jm021113r
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The alpha- and beta-methyl derivatives of 2-phenylethylimidazoline (compounds 7 and 8) and the corresponding enantiomers were prepared and tested with the purpose of studying the role played by the ethylene bridge in modulating I-1- and I-2-IBS selectivity. The alpha-methylation appeared to be extremely critical regarding the affinity and selectivity for the I-1-IBS subtypes (I-1/I-2 = 186 for imidazoline 7) and the stereospecificity of interaction (eudismic ratio (S)-(-)7/(R)-(+)-7 = 5888). Instead, even if in a more limited fashion, the P-methylation tended toward I-2-IBS selectivity (I2I1 = 50 for imidazoline 8). The unsubstituted compound 4 (I-2/I-1 = 1479) proved to be considerably more potent and selective with respect to I-2-IBS subtypes.
引用
收藏
页码:2169 / 2176
页数:8
相关论文
共 56 条
[1]   Synthesis and pharmacological evaluation of imidazoline sites I1 and I2 selective ligands [J].
Anastassiadou, M ;
Danoun, S ;
Crane, L ;
Baziard-Mouysset, G ;
Payard, M ;
Caignard, DH ;
Rettori, MC ;
Renard, P .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (03) :585-592
[2]  
ATLAS D, 1984, EUR J BIOCHEM, V144, P287, DOI 10.1111/j.1432-1033.1984.tb08462.x
[3]   Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands [J].
Boronat, MA ;
Olmos, G ;
García-Sevilla, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (01) :175-185
[4]  
BOUSQUET P, 1984, J PHARMACOL EXP THER, V230, P232
[5]   Drugs acting on imidazoline receptors - A review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection [J].
Bousquet, P ;
Feldman, J .
DRUGS, 1999, 58 (05) :799-812
[6]   THE IMIDAZOLINE PREFERRING RECEPTOR - BINDING-STUDIES IN BOVINE, RAT AND HUMAN BRAIN-STEM [J].
BRICCA, G ;
DONTENWILL, M ;
MOLINES, A ;
FELDMAN, J ;
BELCOURT, A ;
BOUSQUET, P .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 162 (01) :1-9
[7]   An unexpected central hypertensive effect of the new imidazoline compound benazoline [J].
Bruban, V ;
Feldman, J ;
Dontenwill, M ;
Greney, H ;
Brasili, L ;
Giannella, M ;
Pigini, M ;
Bousquet, P .
IMIDAZOLINE RECEPTORS AND THEIR ENDOGENOUS LIGANDS: CURRENT CONCEPTS AND THERAPEUTIC POTENTIAL, 1999, 881 :102-105
[8]   Respective contributions of α-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs [J].
Bruban, V ;
Feldman, J ;
Greney, H ;
Dontenwill, M ;
Schann, S ;
Jarry, C ;
Payard, M ;
Boutin, J ;
Scalbert, E ;
Pfeiffer, B ;
Renard, P ;
Vanhoutte, P ;
Bousquet, P .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (02) :261-266
[9]   Induction of reactive astrocytosis and prevention of motoneuron cell death by the I2-imidazoline receptor ligand LSL 60101 [J].
Casanovas, A ;
Olmos, G ;
Ribera, J ;
Boronat, MA ;
Esquerda, JE ;
García-Sevilla, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (08) :1767-1776
[10]   Clonidine-displacing substance and irs putative role in control of insulin secretion: A minireview [J].
Chan, SLF .
GENERAL PHARMACOLOGY, 1998, 31 (04) :525-529